| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
| ANK2 |
ankyrin 2, neuronal |
4q25-q26 |
1(0/1/0)
|
| QDPR |
quinoid dihydropteridine reductase |
4p15.31 |
1(1/0/0)
|
| SORCS2 |
sortilin-related VPS10 domain containing receptor 2 |
4p16.1 |
5(3/2/0)
|
| NDST3 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 |
4q26 |
1(1/0/0)
|
| WFS1 |
Wolfram syndrome 1 (wolframin) |
4p16.1 |
7(1/6/0)
|
| RNF212 |
ring finger protein 212 |
4p16.3 |
1(0/0/1)
|
| RNF4 |
ring finger protein 4 |
4p16.3 |
1(0/0/1)
|
| LNX1 |
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
4q12 |
1(1/0/0)
|
| USP46 |
ubiquitin specific peptidase 46 |
4q12 |
1(0/1/0)
|
| CFAP97 |
cilia and flagella associated protein 97 |
4q35.1 |
1(0/1/0)
|
| TACC3 |
transforming, acidic coiled-coil containing protein 3 |
4p16.3 |
1(1/0/0)
|
| GABRB1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
4p12 |
3(2/0/1)
|
| PI4K2B |
phosphatidylinositol 4-kinase type 2 beta |
4p15.31 |
1(0/1/0)
|
| KIAA1430 |
cilia and flagella associated protein 97 |
4q35.1 |
0
|
| EPHA5 |
EPH receptor A5 |
4q13.1 |
1(1/0/0)
|
| SLC2A9 |
solute carrier family 2 (facilitated glucose transporter), member 9 |
4p16.1 |
1(0/0/1)
|
| KIAA1239 |
NACHT and WD repeat domain containing 2 |
4p14 |
0
|
| PDLIM5 |
PDZ and LIM domain 5 |
4q22 |
5(4/1/0)
|
| IGFBP7 |
insulin-like growth factor binding protein 7 |
4q12 |
2(1/1/0)
|
| TRIML2 |
tripartite motif family-like 2 |
4q35.2 |
1(0/1/0)
|
| DGKQ |
diacylglycerol kinase, theta 110kDa |
4p16.3 |
1(0/0/1)
|
| ADRA2C |
adrenoceptor alpha 2C |
4p16.3 |
1(0/1/0)
|
| FSTL5 |
follistatin-like 5 |
4q32.3 |
1(0/0/1)
|
| DRD5 |
dopamine receptor D5 |
4p16.1 |
2(0/2/0)
|
| EVC |
Ellis van Creveld syndrome |
4p16 |
1(0/0/1)
|
| NPFFR2 |
neuropeptide FF receptor 2 |
4q21 |
1(0/1/0)
|
| FGFRL1 |
fibroblast growth factor receptor-like 1 |
4p16 |
1(0/0/1)
|
| MAPK10 |
mitogen-activated protein kinase 10 |
4q22-q23 |
1(0/1/0)
|
| CLOCK |
clock circadian regulator |
4q12 |
12(5/7/0)
|
| AFF1 |
AF4/FMR2 family, member 1 |
4q21.3 |
1(0/1/0)
|
| GABRA4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
4p12 |
2(2/0/0)
|
| HGFAC |
HGF activator |
4p16 |
1(0/0/1)
|
| MARCH1 |
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
4q32.2 |
1(0/1/0)
|
| PALLD |
palladin, cytoskeletal associated protein |
4q32.3 |
1(1/0/0)
|
| KCNIP4 |
Kv channel interacting protein 4 |
4p15.32 |
1(0/1/0)
|
| WDR1 |
WD repeat domain 1 |
4p16.1 |
1(0/0/1)
|
| HTT |
huntingtin |
4p16.3 |
1(0/0/1)
|
| CHRNA9 |
cholinergic receptor, nicotinic, alpha 9 (neuronal) |
4p14 |
2(0/2/0)
|
| FAM149A |
family with sequence similarity 149, member A |
4q35.1 |
1(0/1/0)
|
| MTNR1A |
melatonin receptor 1A |
4q35 |
1(0/1/0)
|
| NR3C2 |
nuclear receptor subfamily 3, group C, member 2 |
4q31 |
1(1/0/0)
|
| DHX15 |
DEAH (Asp-Glu-Ala-His) box helicase 15 |
4p15.3 |
1(1/0/0)
|
| LRP2BP |
LRP2 binding protein |
4q35.1 |
1(0/1/0)
|
| POLN |
polymerase (DNA directed) nu |
4p16.3 |
1(0/0/1)
|
| LGI2 |
leucine-rich repeat LGI family, member 2 |
4p15.31 |
1(1/0/0)
|
| LRBA |
LPS-responsive vesicle trafficking, beach and anchor containing |
4q13 |
1(0/0/1)
|
| PPP2R2C |
protein phosphatase 2, regulatory subunit B, gamma |
4p16.1 |
2(1/1/0)
|
| IRF2 |
interferon regulatory factor 2 |
4q34.1-q35.1 |
1(1/0/0)
|
| NWD2 |
NACHT and WD repeat domain containing 2 |
4p14 |
1(0/0/1)
|
| GPR78 |
G protein-coupled receptor 78 |
4p16.1 |
2(2/0/0)
|
| ZNF732 |
zinc finger protein 732 |
4p16.3 |
1(0/0/1)
|